Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia.
about
Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTORErythropoietin and diabetes mellitusEyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilaritiesStem cell guidance through the mechanistic target of rapamycinCutting through the complexities of mTOR for the treatment of strokeDriving neural regeneration through the mammalian target of rapamycinErythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyNew Insights for Oxidative Stress and Diabetes MellitusNovel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic diseaseMelatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways.WISP1: Clinical insights for a proliferative and restorative member of the CCN familyTaking aim at Alzheimer's disease through the mammalian target of rapamycinRegeneration in the nervous system with erythropoietinPicking a bone with WISP1 (CCN4): new strategies against degenerative joint diseaseProgramming apoptosis and autophagy with novel approaches for diabetes mellitus.Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models.mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.Therapeutic targets for cancer: current concepts with PI 3-K, Akt, & mTOR.The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway.Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.FoxO proteins in the nervous system.
P2860
Q26749047-A65ED8A4-4F40-474F-9FA2-B9C275C88CF2Q26777878-155551CA-E5A8-43BD-93E5-AB02CF4C5172Q26782080-AC0765A4-E677-4DA4-84C0-8E6C6EBA4D66Q26795544-9849790C-B26E-4261-8BBC-0C716F992F5EQ26851291-CC7C1925-E68F-4077-BC0D-8234A3C14751Q27027516-C288976A-6153-43D0-8323-C16E74D128C1Q28066377-F26339C6-5345-4588-9D72-995D475FD1B2Q28080679-233327CA-E7CD-4A3C-8BFA-FC83614E5BE5Q28085715-467D6320-BC25-403A-93A1-D9E65913F149Q34358832-671F105B-DDA9-4CA0-9403-26815F7A130AQ34381111-2BEC039F-587B-4CBE-A70E-C8FB7D165B7CQ34603651-B7515323-15FD-405A-84AC-2D556E394568Q36247651-6C4D18A3-A7B2-462A-80EA-6D4A1710B723Q36585324-00AE1BBF-2895-4BA5-AC0D-914A0CE2678DQ38367977-C3E845A6-C95A-42C2-9A21-36E525B197DFQ38607849-AB1F4492-8931-414B-8865-4576E4563052Q38789540-2A4DE657-D93C-4DD2-B983-13A9AF88F9D8Q41082884-A1E22C77-3AAD-4BEF-B1F5-052CF5D1B139Q41273323-C5D10AF2-8381-4F71-BCE5-34E877D20945Q42031136-204595E9-40E9-4D61-BFD1-1A4E23FA0618Q43158408-BC7234FF-4ED7-422B-81DC-CB06D96744AEQ48060988-925D2D7B-BE84-4C3F-BEA6-7F1F07C721C8Q51761339-195D855B-260F-40F7-ACC9-EF84986CF3EAQ52361076-E32E7F2D-4D7E-4141-A0EB-D15BBED4EA6DQ53622309-28FF71B9-EA21-4C22-A3D4-A772BD18C485
P2860
Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tuberous sclerosis protein 2 ( ...... amyloid toxicity in microglia.
@ast
Tuberous sclerosis protein 2 ( ...... amyloid toxicity in microglia.
@en
type
label
Tuberous sclerosis protein 2 ( ...... amyloid toxicity in microglia.
@ast
Tuberous sclerosis protein 2 ( ...... amyloid toxicity in microglia.
@en
prefLabel
Tuberous sclerosis protein 2 ( ...... amyloid toxicity in microglia.
@ast
Tuberous sclerosis protein 2 ( ...... amyloid toxicity in microglia.
@en
P2093
P2860
P1476
Tuberous sclerosis protein 2 ( ...... amyloid toxicity in microglia.
@en
P2093
Kenneth Maiese
Shaohui Wang
Yan Chen Shang
Zhao Zhong Chong
P2860
P356
10.2174/156720213804806007
P577
2013-02-01T00:00:00Z